Could cause temporary or reversible harm; serious harm is unlikely.
Lack of Assurance of Sterility
| Brand name | BUPIVACAINE HYDROCHLORIDE |
| Generic name | BUPIVACAINE HYDROCHLORIDE |
| Active ingredient(s) | BUPIVACAINE HYDROCHLORIDE |
| Distributed by / for | Huons Co., Ltd. |
| NDC | 73293-0002-1 |
| Full product label | Bupivacaine Hydrochloride 0.75% in 8.25% Dextrose Injection, USP (15 mg/2 mL) (7.5 mg/mL) ampules, Rx only, Manufactured by: Houns Co., Ltd, 100, Bio valley, Je-cheor-Si, Chungcheongbuk-dc, Korea, NDC 73293-0002-1 (2 mL ampule), NDC 73293-0002-2 (50 x 2 Single-dose ampules); Distributed: Brookfield Pharmaceuticals, LLC, Brookfield, WI 53005, Made in S. Korea, NDC 71351-022-02 (ampule), NDC 71351-022-10 (10 count ampules), NDC 71351-022-50 (50 count ampules) |
| Recalling firm | Huons Co., Ltd. |
| Distribution | USA Nationwide. |
| Quantity | 3,260,170 ampules |
| Recall initiated | 2026-04-02 |
| Report date | 2026-04-22 |
| Recall completed | — |
| Recall number | D-0530-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Jecheon N/A Korea (the Republic of) |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗